Antibodies to human brain spectrin in Alzheimer's disease

Journal of Neuroimmunology

Volumn 68, Issue 1-2, 1996, Pages 39-44

  Vásquez, Jesús ^a   Fernández Shaw, Clara ^a   Marina, Anabel ^a   Haas, Cristina ^a   Cacabelos, Ramón ^b   Valdivieso, Fernando ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Institute for CNS Disorders   (Spain)

Author keywords

Alzheimer's disease; Autoantibodies; Brain spectrin; Immune response

Indexed keywords

AUTOANTIBODY; SPECTRIN;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; HUMAN; PRIORITY JOURNAL;

EID: 0030219845     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00065-3     Document Type: Article

References (26)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R), 3rd Ed. Revised. Washington, DC.
2. Bahr B.H., Vanderklish P.W., Ha L.W., Tin M.T., Lynch G. Spectrin breakdown products increase with age in telencephalon of mouse brain. Neuroscience Lett. 131:1991;237-240.
3. Chapman J., Bachar O., Korczyn A., Wertman E., Michaelson D. Alzheimer's disease antibodies bind specifically to a neurofilament protein in torpedo cholinergic neurons. J. Neurosci. 9:1989;2710-2717.
4. Chapman J., Bachar O., Korczyn A., Wertman E., Michaelson D. Antibodies to cholinergic neurons in Alzheimer's disease. J. Neurochem. 51:1988;479-485.
5. Davis J., Bennet V. Brain Spectrin: Isolation of Subunits and formation of hybrids with erythrocyte spectrin subunits. J. Biol. Chem. 258:1983;7757-7766.
6. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res. 12:1975;189-198.
7. Fillit H.M., Kemeny E., Luine V., Weksler M.E., Zabriskie J.B. Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type. J. Gerontol. 42:1987;180-184.
8. Glenney J.R., Glenney P., Osborn M., Weber K. A F-actin- and calmodulin-binding protein from isolated intestinal brush borders has a morphology related to spectrin. Cell. 28:1982;843-852.
9. Goodman S.R., Zagon I.S. The neural cell spectrin skeleton: a review. Am. J. Physiol. 250:1986;C347-C360.
10. Harlow, E. and Lane, D. (1988) Antibodies, a laboratory manual. Cold Spring Harbor Laboratory.
11. Kalaria R.N. The immunopathology of Alzheimer's disease and some related disorders. Brain Pathol. 3:1993;333-347.
12. Katzman R. The prevalence and malignancy of Alzheimer's disease: a major killer. Arch. Neurol. 33:1976;217-218.
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
14. Lynch G., Baudry M. The biochemistry of memory: a new and specific hypothesis. Science. 224:1984;1057-1063.
15. Lynch, G., Bahr, B.A. and Vanderklish, P.W. (1991) Induction and stabilization of long-term potentiation. In: ed. P. Ascher, D.W. Choi and Y. Christen, Glutamate, Cell Death and Memory. Springer-Verlag, Berlin, pp. 45-60.
16. Masliash E., Iimoto D.S., Saitoh T., Hansen L.A., Terry R.D. Increased immunoreactivity of brain spectrin in Alzheimer disease: a marker for synapse loss? Brain Res. 531:1990;36-44.
17. Masliash E., Hansen L., Mallory M., Albright T., Terry R.D. Abnormal brain spectrin immunoreactivity in uting neurons in Alzheimer disease. Neurosci. Lett. 129:1991;1-5.
18. McKhan G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of NINCDS-ADRDA Work Group. Neurology. 34:1994;939-944.
19. McRae-Deguerce A., Booj S., Haglid K., Rosengren L., Karlsson J.E., Karlsson I., Wallin A., Svennerholm L., Gottfries C.G., Dahlstrom A. Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system. Proc. Natl. Acad. Sci. USA. 84:1987;9214-9218.
20. Murray, R. and Spiegel, D. (1961) Estadística. McGraw-Hill, México.
21. Peterson C., Vanderklish P., Seubert P., Cotman C., Lynch G. Increased spectrin proteolysis in fibroblasts from aged and Alzheimer donors. Neurosci. Lett. 121:1991;239-243.
22. Reisberg, B., Ferris, S.H. and De Leon, M.J. (1985) Senile dementia of the Alzheimer type: Diagnosis and differential diagnostic features with spatial reference to functional assessment staging. In: ed. J. Traber and W.H. Gispen, Senile Dementia of the Alzheimer type. Springer-Verlag, Berlin pp. 18-37.
23. Rosenfeld J., Capdeville J., Guillemot J.C., Ferrara P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. anal. Biochem. 203:1992;173-179.
24. Saitoh T., Masliah E., Baum L., Sundsmo M., Flanagan L., Vikrakumar R.et al. Degradation of proteins in the membrane-cytoskeleton complex in Alzheimer's disease. Annal. NY Acad. Sci. 674:1993;180-192.
25. Stone, K.L. and Williams, K.R. (1993) Enzymatic digestion of proteins and HPLC peptide isolation. In: ed. P. Matsudaira, A Practical Guide to Protein and Peptide Purification for Microsequencing. Academic Press, Inc., New York, pp. 43-69.
26. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some aplications. Proc. Natl. Acad. Sci. USA. 76:1970;4350-4354.